Question explored with the scientific record
Vitamin K
Vitamin K is a real nutrient with real jobs, but the evidence here is mostly about correcting deficiency and bone markers, not about healthy people taking it.
Vitamin K is required for blood clotting and for activating proteins that regulate calcium in bone and blood vessels [1][2]. The clearest evidence in this retrieval is for correcting a deficiency, not for supplementing the already-replete. In severely disabled children on tube feeding, vitamin K deficiency caused bleeding and abnormal clotting that normalized after vitamin K was given [6]. In infants with liver disease, vitamin K deficiency produced brain bleeds that resolved with vitamin K and plasma [3][5]. In an 85-year-old on antibiotics and fasting, severe deficiency corrected rapidly after intravenous vitamin K [4]. These are rescue scenarios, and the benefit is well established.
For bone, a narrative review claims vitamin K2 forms may preserve bone density and reduce fractures when combined with calcium, but flags interactions with blood thinners [1]. That is a review-level assertion, not a hard-outcome trial. No fracture or mortality trial of vitamin K appears in this retrieval.
| Situation | What the evidence shows |
|---|---|
| Deficiency with bleeding | Rapid correction after vitamin K [4][6] |
| Liver disease in infants | Brain bleeds tied to deficiency [3][5] |
| Healthy adults, bone | Review-level claim only [1] |
| On warfarin | Interaction risk, needs monitoring [1][7] |
The real caution is drug interaction. Vitamin K reverses warfarin, and a man with a dangerously high INR improved after a small vitamin K dose plus a warfarin reduction [7]. If you take a blood thinner, self-dosing vitamin K is not benign.
This retrieval cannot see fracture-outcome trials, cancer or mortality data, or dosing studies in healthy adults. Those would settle whether routine supplementation helps anyone who is not deficient.
My call: use vitamin K to treat documented deficiency, especially in infants with liver disease or anyone on prolonged antibiotics and poor intake; routine supplementation in healthy adults is not supported by hard outcomes here. Confidence: moderate for deficiency treatment, low for routine supplementation.
Sources used 7
-
Picking a bone with contemporary osteoporosis management: Nutrient strategies to enhance skeletal integrity
A narrative review arguing that nutritional micronutrients—vitamin D, strontium, vitamin K, and essential fatty acids—can meaningfully complement conventional osteoporosis treatments by improving bone strength and reducing fracture risk, while highlighting current evidence, gaps…
DOI: 10.1016/j.clnu.2006.08.004 -
Modifying Phosphate Toxicity in Chronic Kidney Disease
Phosphate toxicity in CKD is mediated by calciprotein particles and FGF23 and modified by magnesium, calcium, α-klotho, vitamin K status, zinc, and pH, suggesting targets beyond phosphate lowering.
DOI: 10.3390/toxins11090522 -
Brain haemorrhage in five infants with coagulopathy
A retrospective case series describing five infants from the Oxford region who presented with spontaneous intracranial haemorrhage due to inherited coagulopathies or related conditions (including vitamin K deficiency with Alagille’s syndrome and alpha-1 antitrypsin deficiency), …
DOI: 10.1136/adc.88.12.1119 -
Severe coagulation abnormality during treatment for ischemic enteritis in an older patient taking a direct oral anticoagulant
An elderly patient on the direct oral anticoagulant edoxaban for ischemic enteritis developed severe vitamin K deficiency–related coagulopathy during fasting and antibiotic therapy, which rapidly corrected after vitamin K administration.
DOI: 10.3143/geriatrics.56.74 -
Comparison of biliary atresia with and without intracranial hemorrhage
This single-center retrospective study of 63 biliary atresia patients undergoing Kasai portoenterostomy compares those with intracranial hemorrhage (ICH) to those without, finding earlier age at Kasai, lower hepatobiliary enzyme levels but more progressive coagulopathy in the IC…
DOI: 10.1016/j.jpedsurg.2018.04.031 -
Vitamin K Deficiency in Severely Disabled Children
A retrospective study of 21 severely disabled children to determine the prevalence, risk factors, and clinical features of vitamin K deficiency, and to show that vitamin K supplementation rapidly corrected associated coagulopathy and bleeding tendencies.
DOI: 10.1177/08830738030180020801 -
Anticoagulant-induced oral bleeding
In a 69-year-old man taking warfarin 5 mg/day with an INR of 8.26, purple hemorrhagic oral lesions on the soft palate and tongue resolved within one week after a single 2.5 mg subcutaneous vitamin K dose and warfarin dose reduction.
DOI: 10.14295/bds.2017.v20i3.1379